4K7I | HUMAN PEROXIREDOXIN 5 with a fragment | date | 2013-04-17 |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
authors | Guichou, J.F. | ||||||||||||||
compound | source | ||||||||||||||
symmetry |
| ||||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | 2.25 | ||||||||||||
ligand | CAQ, DMS | enzyme |
| ||||||||||||
Gene Ontology |
| ||||||||||||||
Primary reference | Comparing Binding Modes of Analogous Fragments Using NMR in Fragment-Based Drug Design: Application to PRDX5., Aguirre C, Brink TT, Guichou JF, Cala O, Krimm I, PLoS One. 2014 Jul 15;9(7):e102300. doi: 10.1371/journal.pone.0102300., eCollection 2014. PMID:25025339 |
Data retrieval |
View 4K7I in 3D |
Visual 3D analysis of 4K7I |
Structure-derived information |
Sequence-derived information |
Other resources with information on 4K7I |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |